UNC Institute for Global Health and Infectious Diseases Revenue and Competitors
Estimated Revenue & Valuation
- UNC Institute for Global Health and Infectious Diseases's estimated annual revenue is currently $12.6M per year.
- UNC Institute for Global Health and Infectious Diseases's estimated revenue per employee is $243,000
Employee Data
- UNC Institute for Global Health and Infectious Diseases has 52 Employees.
- UNC Institute for Global Health and Infectious Diseases grew their employee count by 6% last year.
UNC Institute for Global Health and Infectious Diseases's People
Name | Title | Email/Phone |
---|---|---|
1 | Undergraduate Research Assistant | Reveal Email/Phone |
2 | Research Assistant | Reveal Email/Phone |
3 | Accounting Technician | Reveal Email/Phone |
UNC Institute for Global Health and Infectious Diseases Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $76.6M | 258 | 0% | N/A | N/A |
#2 | $109.4M | 324 | -1% | N/A | N/A |
#3 | $7.8M | 36 | -3% | N/A | N/A |
#4 | $14.3M | 59 | -3% | N/A | N/A |
#5 | $27.3M | 101 | 17% | N/A | N/A |
#6 | $17M | 70 | -7% | N/A | N/A |
#7 | $1.6M | 10 | -68% | N/A | N/A |
#8 | $421.5M | 1115 | N/A | N/A | N/A |
#9 | $29.7M | 110 | -21% | N/A | N/A |
#10 | $58.2M | 196 | 8% | N/A | N/A |
What Is UNC Institute for Global Health and Infectious Diseases?
The mission of the Institute for Global Health & Infectious Diseases is to harness the full resources of the University and its partners to solve global health problems, reduce the burden of disease, and cultivate the next generation of global health leaders.
keywords:N/AN/A
Total Funding
52
Number of Employees
$12.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.9M | 53 | -2% | N/A |
#2 | $10.9M | 54 | 6% | N/A |
#3 | $7.5M | 54 | 29% | N/A |
#4 | $6.3M | 54 | -2% | N/A |
#5 | N/A | 55 | 45% | N/A |